April 5, 2011

Jarrow Formulas® Launches Two New QH-absorb® Products

Los Angeles, CA, April 5, 2011  Jarrow Formulas®, Inc., a global wellness and nutrition product company headquartered in Los Angeles, CA, has announced the launch of two new QH-absorb products: A 100 mg 120 softgel size and a 200 mg 60 softgel size. QH-absorb, which features the active form of Co-Q10 known as ubiquinol, offers improved bioavailability over standard Co-Q10 supplements (ubiquinone) and is able to deliver Co-Q10 in its native antioxidant-ready (reduced) form. While standard Co-Q10 (ubiquinone) supplements can be activated in the body, this activation may be less efficient in some individuals due to age, state of health or genetics.

QH-absorb, like Q-absorb, uses an all-natural liposome-based delivery system to improve absorption and contains no detergents or surfactants. This delivery system has been validated in multiple trials to significantly improve Co-Q10 absorption over powdered Co-Q10 dosage forms. Jarrow Formulas QH-absorb (ubiquinol) is derived from Co-Q10 that is manufactured via a yeast-fermentation process and consists only of the natural trans- configuration. This is the same form that is synthesized by the human body.

Jarrow Formulas ubiquinol is supplied by the Kaneka Corporation, the world's largest manufacturer of Co-Q10. The Kaneka production process yields Co-Q10 of the highest purity and potency available.



Jarrow Formulas is a direct contributor to research on Co-Q10. It has funded several clinical trials on the nutrient as well as acting as a sponsor for the international society that promotes research and education regarding coenzyme Q10.